Jing-Yao Dai (Jingyao Dai)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

ACS applied materials & interfaces

Journal of cellular and molecular medicine

Cancer medicine

Fourth Military Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Fourth Military Medical University

China

PHD :: Hepatobiliary Surgery

Publications

Cheng Jiang, Lei Zheng, Yu-Jie Yan, Miao Wang, Xiao-Jing Liu, Jing-Yao Dai
A Supramolecular Antibiotic Targeting Drug-Resistant Pseudomonas aeruginosa through the Inhibition of Virulence Factors and Activation of Acquired Immunity. ACS applied materials & interfaces 16 (32) (2024)
Cheng Jiang, Lei Zheng, Yu-Jie Yan, Miao Wang, Xiao-Jing Liu, Jing-Yao Dai
A Supramolecular Antibiotic Targeting Drug-Resistant Pseudomonas aeruginosa through the Inhibition of Virulence Factors and Activation of Acquired Immunity. ACS applied materials & interfaces 16 (32) (2024)
Cheng Jiang, Lei Zheng, Yu-Jie Yan, Miao Wang, Xiao-Jing Liu, Jing-Yao Dai
A Supramolecular Antibiotic Targeting Drug-Resistant Pseudomonas aeruginosa through the Inhibition of Virulence Factors and Activation of Acquired Immunity. ACS applied materials & interfaces 16 (32) (2024)
Cheng Jiang, Lei Zheng, Yu-Jie Yan, Miao Wang, Xiao-Jing Liu, Jing-Yao Dai
A Supramolecular Antibiotic Targeting Drug-Resistant Pseudomonas aeruginosa through the Inhibition of Virulence Factors and Activation of Acquired Immunity. ACS applied materials & interfaces (2024)
Cheng Jiang, Lei Zheng, Yu-Jie Yan, Miao Wang, Xiao-Jing Liu, Jing-Yao Dai
A Supramolecular Antibiotic Targeting Drug-Resistant Pseudomonas aeruginosa through the Inhibition of Virulence Factors and Activation of Acquired Immunity. ACS applied materials & interfaces 16 (32) (2024)
Ji-Min Dai, Wei-Nan Guo, Yi-Zhou Tan, Kun-Wei Niu, Jia-Jia Zhang, Cheng-Li Liu, Xiang-Min Yang, Kai-Shan Tao, Zhi-Nan Chen, Jing-Yao Dai
Wogonin alleviates liver injury in sepsis through Nrf2-mediated NF-κB signalling suppression. Journal of cellular and molecular medicine 25 (12) (2021)
Jimin Dai, Qichao Huang, Kunwei Niu, Bo Wang, Yijie Li, Chen Dai, Zhinan Chen, Kai Shan Tao, Jing-Yao Dai
Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma. Cancer medicine 7 (11) (2018)

Jing-Yao Dai.css-eqlu8i{font-size:small;padding-left:4px;} (Jingyao Dai)

Publication Activity (10 Years)

Top Topics

Top Venues

Jing-Yao Dai (Jingyao Dai)